Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Initiates Coverage On HCA Healthcare with Overweight Rating, Announces Price Target of $356

Author: Benzinga Newsdesk | March 06, 2024 07:38am
Barclays analyst Andrew Mok initiates coverage on HCA Healthcare (NYSE:HCA) with a Overweight rating and announces Price Target of $356.

Posted In: HCA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist